article_metadata: Wanying Liu Jiaying Wu Xi Ming Qi Zhang Delian Zhou Rubing Zheng Mi Zhou Zhen Shang Liting Chen Xiaojian Zhu Yi Xiao
article_metadata: 10.3389/fimmu.2024.1346001
article_metadata: Front Immunol
article_metadata: 2024 Feb 5:15:1346001.
article_metadata: car t cell therapy t-cell non-hodgkin lymphoma anaplastic large cell lymphoma autologous stem cell transplantation crizotinib
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/38375471/
article_metadata: Hematopoietic Stem Cell Transplantation Immunoconjugates / therapeutic use Lymphoma, Large-Cell, Anaplastic / drug therapy Lymphoma, Large-Cell, Anaplastic / pathology Receptors, Chimeric Antigen / therapeutic use
article_metadata: Hematopoietic Stem Cell Transplantation Immunoconjugates / therapeutic use Lymphoma, Large-Cell, Anaplastic / drug therapy Lymphoma, Large-Cell, Anaplastic / pathology Receptors, Chimeric Antigen / therapeutic use Case Reports Research Support, Non-U.S. Gov't Brentuximab Vedotin / therapeutic use Crizotinib / therapeutic use Humans Immunotherapy, Adoptive Neoplasm Recurrence, Local / drug therapy Receptor Protein-Tyrosine Kinases / genetics Transplantation, Autologous Brentuximab Vedotin Crizotinib Receptors, Chimeric Antigen Immunoconjugates Receptor Protein-Tyrosine Kinases
article_metadata: PMC10875076
article_metadata: 38375471
article_metadata: Case report: The utilization of crizotinib and brentuximab vedotin as a bridge to autologous stem cell transplantation and followed by CD30-directed CAR-T cell therapy in relapsed/refractory ALK+ ALCL
article_metadata: 2024